Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Total Current Liabilities (2020 - 2025)

iSpecimen has reported Total Current Liabilities over the past 6 years, most recently at $6.2 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $6.2 million for Q4 2025, up 7.99% from a year ago — trailing twelve months through Dec 2025 was $6.2 million (up 7.99% YoY), and the annual figure for FY2025 was $6.2 million, up 7.99%.
  • Total Current Liabilities for Q4 2025 was $6.2 million at iSpecimen, up from $5.7 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for ISPC hit a ceiling of $6.3 million in Q3 2024 and a floor of $2.0 million in Q2 2022.
  • Median Total Current Liabilities over the past 5 years was $4.9 million (2025), compared with a mean of $4.4 million.
  • Biggest five-year swings in Total Current Liabilities: crashed 88.68% in 2021 and later soared 103.25% in 2024.
  • iSpecimen's Total Current Liabilities stood at $2.5 million in 2021, then skyrocketed by 70.87% to $4.3 million in 2022, then soared by 41.29% to $6.0 million in 2023, then dropped by 4.6% to $5.8 million in 2024, then grew by 7.99% to $6.2 million in 2025.
  • The last three reported values for Total Current Liabilities were $6.2 million (Q4 2025), $5.7 million (Q3 2025), and $5.2 million (Q2 2025) per Business Quant data.